Showing results (201-210 of 325) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2016
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)Zhe Li Salie, Karen A Kirby, Eleftherios Michailidis, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 1, 2022
Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in JapanNobumasa Okumura, Shinya Tsuzuki, Sho Saito, et al.
The Journal of Biological Chemistry|February 16, 2006
Structural and molecular interactions of CCR5 inhibitors with CCR5Kenji Maeda, Debananda Das, Hiromi Ogata-Aoki, et al.
The Journal of Biological Chemistry|July 20, 2007
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerizationYasuhiro Koh, Shintaro Matsumi, Debananda Das, et al.
ACS Omega|February 2, 2026
Impact of Single Halogen Atom Substitutions on Antiviral Profile of Inhibitors Targeting SARS-CoV‑2 Main ProteaseHaydar Bulut, Nobuyo Higashi-Kuwata, Hiromi Ogata-Aoki, et al.
ACS Infectious Diseases|May 21, 2024
Discovery of Potent DAG-Lactone Derivatives as HIV Latency Reversing AgentsTakahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.
Global Health & Medicine|May 3, 2021
Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, JapanShohei Yamamoto, Akihito Tanaka, Shinji Kobayashi, et al.
Japanese Journal of Clinical Oncology|March 12, 2003
A dose-finding study of glycosylated G-CSF (Lenograstim) combined with CHOP therapy for stem cell mobilization in patients with non-Hodgkin's lymphomaKunihiko Takeyama, Michinori Ogura, Yasuo Morishima, et al.
Pageof 33